Men's Health News

RSS

Male hormone testosterone may increase risk of colon cancer

Previous cancer research has revealed that women are less likely than men to suffer from non-sex specific cancers such as cancer of the colon, pancreas and stomach. Scientists theorized that perhaps this trend was due to a protecting effect created by female hormones, such as estrogen, that help prevent tumors from forming. Now, researchers at the University of Missouri have found evidence suggesting that the male hormone testosterone may actually be a contributing factor in the formation of colon cancer tumors.

11 Dec 2014

Prolongz drug achieves No. 1 spot in the personal care category

Prolongz, the all-natural FDA registered over-the-counter homeopathic drug that helps in the prevention of premature ejaculation, has been ranked No. 1 in the personal care category for July, August and September of 2014 by the Jordan Whitney Greensheet.

10 Dec 2014

Cancer Council urges partners of men diagnosed with prostate cancer to reach out for support

Cancer Council is calling on partners of men with prostate cancer to reach out for support, with research showing partners experience high levels of distress related to the diagnosis of their loved one.

10 Dec 2014

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported that it will initiate a pre-clinical development program of its next generation drug CF602 for the indication of sexual dysfunction. Upon successful completion, the company intends to file an IND with the FDA to allow human Phase I studies.

9 Dec 2014

BAZ2A protein directly influences the aggressiveness of prostate cancer

A protein that influences the epigenetic characteristics of tumor cells is directly linked to the grade of malignancy of prostate cancer. This key discovery has been made by a team of scientists from the German Cancer Research Center, the University of Zurich, Hamburg-Eppendorf University Hospital, Heidelberg University, and other institutes in a study of 7,700 samples of tumor tissue.

9 Dec 2014

Simple rectal swab cultures can thwart drug-resistant E. coli in patients undergoing TRUSBx procedures

Some infections after prostate biopsy due to drug-resistant Escherichia coli can be thwarted by simple rectal swab cultures prior to the procedure. The cultures test for antibiotic-resistant E. coli, and the findings are used to direct the selection of antimicrobial prophylaxis used for the procedure, according to Rhode Island Hospital researchers.

9 Dec 2014

Cellular mechanisms of alcohol dependence: an interview with Dr Sanna, TSRI

In the brain there are both excitatory and inhibitory neurotransmitters. These are molecules that are released from nerve endings in the brain and in the periphery and either excite or inhibit other nerve cells, also known as neurons.

8 Dec 2014

Study links poor semen quality to higher risk of various health conditions

A study of more than 9,000 men with fertility problems has revealed a correlation between the number of different defects in a man's semen and the likelihood that the man has other health problems.

6 Dec 2014

Exposure to chemicals used in UOG operations may affect reproductive and developmental health

Unconventional oil and gas (UOG) operations combine directional drilling and hydraulic fracturing, or "fracking," to release natural gas from underground rock. Recent discussions have centered on potential air and water pollution from chemicals used in these processes and how it affects the more than 15 million Americans living within one mile of UOG operations.

6 Dec 2014

York researcher examines male attitudes towards self-managing long-term health conditions

A researcher at the University of York, studying male attitudes towards self-managing long-term healthcare issues, has discovered that self-management support is better received by men if it does not threaten aspects of masculine identity.

5 Dec 2014

Are you eating yourself to an early grave?

A new study, published today in The Lancet Diabetes & Endocrinology, has shown that obesity may shorten life expectancy by ≤8 years and reduce the duration of healthy life by ≤19 years as a consequence of developing diabetes and/or cardiovascular disease.

5 Dec 2014

Endocrinologist examines benefits and harms of testosterone therapy

An article in the latest edition of Australian Prescriber looks at the prescribing of testosterone, often used for ‘male menopause’ symptoms such as reduced energy, poor concentration and increased body fat. Over the past decade there has been a steep rise in the amount of testosterone dispensed in Australia and globally.

4 Dec 2014

Study: Common prostate cancer therapy exposes low-risk patients to more adverse side effects

A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate, according to a new study led by researchers at Henry Ford Hospital.

4 Dec 2014

Study explores use of bisphosphonates for men receiving androgen deprivation therapy

Although some guidelines recommend use of bisphosphonates (a class of drugs used to strengthen bone) for men on androgen deprivation therapy, an analysis finds that prescriptions for these drugs remains low, even for those men at high risk of subsequent fractures, according to a study in the December 3 issue of JAMA.

3 Dec 2014

Mediterranean diet improves cardiovascular performance in patients with erectile dysfunction

The Mediterranean diet is linked to improved cardiovascular performance in patients with erectile dysfunction, according to research presented at EuroEcho-Imaging 2014 by Dr Athanasios Angelis from Greece. Patients with erectile dysfunction who had poor adherence to the Mediterranean diet had more vascular and cardiac damage.

3 Dec 2014

Myriad Genetics to highlight clinical data from three Prolaris studies at SUO 2014

Myriad Genetics, Inc. today announced that clinical data from three studies with Prolaris in prostate cancer patients will be highlighted at the 2014 Society of Urologic Oncology Annual Meeting being held tomorrow in Rockville, Md. The new data show that the Prolaris test could save the healthcare system $6 billion over 10 years and that physicians are using the test appropriately to personalize treatment options for their patients.

3 Dec 2014

Prostate cancer patients with life expectancies of less than 10 years receive aggressive treatment

National guidelines recommend that men with low- and intermediate -risk prostate cancer and life expectancies of less than 10 years should not be treated with radiation or surgery, since they are unlikely to live long enough to benefit from treatment. Yet it is unknown whether such men are unnecessarily receiving these aggressive local treatments, putting them at risk for potentially debilitating side effects.

2 Dec 2014

CCR5 receptor plays key role in driving prostate cancer metastases

Although prostate cancer can be successfully treated in many men, when the disease metastasizes to the bone, it is eventually lethal. In a study published online December 1st in the journal Cancer Research, researchers show that the receptor CCR5 best known for its role in HIV therapy, may also be involved in driving the spread of prostate cancer to the bone.

1 Dec 2014

Prevalence of adult smoking is falling in US

The proportion of US adults who smoke has dropped by around 3% (from 2005 to 2013) according to a study conducted by the Centers for Disease Control and Prevention (CDC).

28 Nov 2014

Study finds striking gap in cancer survival between countries and regions

The CONCORD-2 study, published in The Lancet, reports 5-year survival estimates for 25·7 million cancer patients diagnosed with one of 10 common cancers and 75 000 children diagnosed with acute lymphoblastic leukaemia between 1995 and 2009, using individual patient data from 279 cancer registries in 67 countries.

28 Nov 2014

Men's Health News

Male hormone testosterone may increase risk of colon cancer

Prolongz drug achieves No. 1 spot in the personal care category

Cancer Council urges partners of men diagnosed with prostate cancer to reach out for support

Can-Fite to commence pre-clinical development program of CF602 drug for sexual dysfunction

BAZ2A protein directly influences the aggressiveness of prostate cancer

Simple rectal swab cultures can thwart drug-resistant E. coli in patients undergoing TRUSBx procedures

Cellular mechanisms of alcohol dependence: an interview with Dr Sanna, TSRI

Study links poor semen quality to higher risk of various health conditions

Exposure to chemicals used in UOG operations may affect reproductive and developmental health

York researcher examines male attitudes towards self-managing long-term health conditions

Are you eating yourself to an early grave?

Endocrinologist examines benefits and harms of testosterone therapy

Study: Common prostate cancer therapy exposes low-risk patients to more adverse side effects

Study explores use of bisphosphonates for men receiving androgen deprivation therapy

Mediterranean diet improves cardiovascular performance in patients with erectile dysfunction

Myriad Genetics to highlight clinical data from three Prolaris studies at SUO 2014

Prostate cancer patients with life expectancies of less than 10 years receive aggressive treatment

CCR5 receptor plays key role in driving prostate cancer metastases

Prevalence of adult smoking is falling in US

Study finds striking gap in cancer survival between countries and regions

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News